Healthcare Services

Technological improvements in genetic test kits are boosting accuracy and accelerating hereditary testing market growth

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Hereditary Testing Market Expected To Scale Between 2026 And 2030?

The hereditary testing market size has demonstrated significant expansion in recent years. It is anticipated to increase from $6.62 billion in 2025 to $7.23 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.2%. The historical expansion of this market can be linked to improvements in genetic sequencing technologies, a rise in awareness regarding inherited disorders, the broadened scope of clinical genetics programs, a reduction in the cost of genetic testing, and the expansion of diagnostic laboratory networks.

The hereditary testing market is projected to experience substantial growth over the next few years, with its size anticipated to reach $10.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This expansion during the forecast period is driven by factors such as the increasing integration of genomics into routine medical care, a rising demand for precision medicine applications, the broadening of population-scale genetic screening initiatives, the growing adoption of digital genetic data platforms, and an enhanced focus on genomics within preventive healthcare. Prominent trends expected in this period include the increasing uptake of next-generation sequencing tests, a rising demand for predictive and carrier genetic testing, the growing utilization of AI-based variant interpretation, the expansion of prenatal and newborn screening programs, and an intensified focus on personalized genetic counseling.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hereditary-testing-global-market-report

Which Key Drivers Are Affecting The Hereditary Testing Market Development?

The expanding occurrence of genetic conditions is anticipated to fuel the expansion of the hereditary testing market in the future. Genetic conditions are health issues caused by irregularities or changes in an individual’s deoxyribonucleic acid, which can be passed down from parents or emerge spontaneously. A contributing factor to the increase in genetic disorders is the rising age of parents, elevating the probability of genetic mutations being transmitted to children. Hereditary testing assists individuals with genetic disorders by facilitating prompt diagnosis, directing tailored therapies, and aiding family planning through the detection of inherited mutations. For example, in October 2024, data from Cystic Fibrosis Trust, a UK-based charitable organization, showed that the count of patients registered with cystic fibrosis increased to 11,318 in 2023, an uplift from 11,148 in 2022. Consequently, the growing incidence of genetic disorders is propelling the hereditary testing market’s growth.

How Is The Hereditary Testing Market Segmented Across Different Segment Categories?

The hereditary testing market covered in this report is segmented –

1) By Test Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Testing, Other Test Types

2) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Buccal Swabs, Amniotic Fluid And Cord Blood Samples

3) By Technology Used: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Sanger Sequencing, Microarray Technology, Whole Genome Sequencing (WGS)

4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders, Other Applications

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Patients And Consumers

Subsegments:

1) By Predictive Testing: Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Gene Mutation Testing, Lynch Syndrome Testing, Familial Hypercholesterolemia Testing, Huntington’s Disease Testing, Cardiomyopathy Genetic Testing

2) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Carrier Screening, Spinal Muscular Atrophy (SMA) Carrier Screening, Thalassemia Carrier Screening, Sickle Cell Carrier Testing

3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Chorionic Villus Sampling (CVS), Amniocentesis, Expanded Carrier Screening (Prenatal Context), Cell-Free Fetal Deoxyribonucleic Acid Testing

4) By Newborn Screening: Phenylketonuria (PKU) Screening, Congenital Hypothyroidism Screening, Cystic Fibrosis Screening, Sickle Cell Disease Screening, Hearing Loss and Metabolic Disorder Panels

5) By Diagnostic Testing: Rare Disease Genetic Testing, Inherited Cancer Diagnostic Testing, Cardiogenetic Diagnostic Panels, Neurogenetic Disorder Testing, Monogenic Disease Panels

6) By Other Test Types: Pharmacogenomics Testing, Preimplantation Genetic Diagnosis (PGD), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS), Mitochondrial Deoxyribonucleic Acid Testing

What Trends Are Transforming The Hereditary Testing Market?

Leading companies within the hereditary testing market are prioritizing technological advancements in genetic test kits to enhance testing precision, shorten turnaround times, and improve the detection of a wider spectrum of genetic mutations. Genetic test kits are diagnostic instruments designed to analyze an individual’s deoxyribonucleic acid (DNA) to pinpoint genetic mutations or variations linked to inherited conditions or disease predispositions. For example, in July 2023, Devyser Diagnostics AB, a Sweden-based biotechnology company focused on developing, manufacturing, and selling DNA diagnostic kits for hereditary disease testing, introduced two new targeted next-generation sequencing kits: Devyser LynchFAP and Devyser BRCA PALB2. Devyser LynchFAP uniquely allows for a complete analysis of PMS2, overcoming challenges from its pseudogene PMS2CL, alongside nine other crucial genes connected to hereditary colorectal cancer syndromes. Devyser BRCA PALB2 offers a seamless single-tube solution for screening BRCA1, BRCA2, and PALB2 mutations in both blood and tumor samples. This is engineered for streamlined lab workflows, providing efficient, user-friendly sequencing and dedicated software to support confident identification of hereditary cancer risks.

Which Organizations Play A Role In The Hereditary Testing Market Landscape?

Major companies operating in the hereditary testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., CooperSurgical Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, GeneDx LLC, Twist Bioscience Corporation, Color Health Inc., MedGenome Inc, SOPHiA GENETICS SA, Gene By Gene Ltd., Dante Labs Inc., 23mofang Co. Ltd.

Get The Full Hereditary Testing Market Report:

https://www.thebusinessresearchcompany.com/report/hereditary-testing-global-market-report

Which Region Dominates The Hereditary Testing Market By Market Share?

North America was the largest region in the hereditary testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hereditary Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hereditary-testing-global-market-report

Browse Through More Reports Similar to the Global Hereditary Testing Market 2026, By The Business Research Company

Prenatal And Newborn Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Dna Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795